Literature DB >> 10616008

Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individuals.

A Morinobu1, S Kanagawa, M Koshiba, S Sugai, S Kumagai.   

Abstract

OBJECTIVE: To investigate the role of polymorphisms of the glutathione S-transferase M1 (GSTM1) and GSTT1 genes in determining susceptibility to Sjögren's syndrome (SS) and autoantibody production.
METHODS: Polymorphisms of the GSTM1 and GSTT1 genes in 106 Japanese patients with primary SS and in 143 healthy controls were analyzed by polymerase chain reaction.
RESULTS: Frequency of the GSTM1 homozygous null genotype was significantly increased in SS patients compared with controls (57.5% versus 44.1%; P = 0.035). Moreover, a significantly greater frequency of SSA antibodies was found among SS patients with the GSTM1 null genotype than among those with the GSTM1 non-null genotype (P = 0.0013). Frequency of the GSTT1 polymorphism was not different between SS patients and controls.
CONCLUSION: The GSTM1 homozygous null genotype could be a genetic factor that determines susceptibility to SS and may be involved in SSA antibody production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616008     DOI: 10.1002/1529-0131(199912)42:12<2612::AID-ANR15>3.0.CO;2-V

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Sjögren's syndrome: an old tale with a new twist.

Authors:  Byung Ha Lee; Mauro A Tudares; Cuong Q Nguyen
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

Review 2.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

3.  Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans.

Authors:  Ted R Mikuls; Tricia Levan; Karen A Gould; Fang Yu; Geoffrey M Thiele; Kimberly K Bynote; Doyt Conn; Beth L Jonas; Leigh F Callahan; Edwin Smith; Richard Brasington; Larry W Moreland; Richard Reynolds; Angelo Gaffo; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2012-03

4.  Polymorphisms of the mannose binding lectin gene in patients with Sjögren's syndrome.

Authors:  Z Y Wang; A Morinobu; S Kanagawa; S Kumagai
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 5.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

6.  The glutathione S-transferase M1 and P1 polymorphisms and rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2012-10-06       Impact factor: 2.316

7.  Glutathione S-transferase M1 and T1 null genotype frequency distribution among four tribal populations of western India.

Authors:  Prem Chandra Suthar; Pulakes Purkait; Kiran Uttaravalli; B N Sarkar; Rakshit Ameta; Mithun Sikdar
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

Review 8.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

9.  Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.

Authors:  Nezam Altorok; Patrick Coit; Travis Hughes; Kristi A Koelsch; Donald U Stone; Astrid Rasmussen; Lida Radfar; R Hal Scofield; Kathy L Sivils; A Darise Farris; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

10.  Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.

Authors:  Cuong Q Nguyen; Ashok Sharma; Jin-Xiong She; Richard A McIndoe; Ammon B Peck
Journal:  Exp Eye Res       Date:  2008-10-18       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.